Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
37,735
+17,859
+90% +$6.11M 0.18% 85
2026
Q1
$6.99M Buy
+19,876
New +$7.09M 0.15% 82
2025
Q2
Sell
-212
Closed -$66K 84
2025
Q1
$66K Buy
+212
New +$62.6K 0.35% 49

Other funds holding AMGN

Saudi Central Bank's AMGN Position: Q2 2026 in Review

Saudi Central Bank increased its Amgen (AMGN) stake by 90% in Q2 2026, buying an estimated $6.11M and bringing the position to 37,735 shares worth $13.7M. The position accounts for 0.18% of the portfolio, ranked #85.

Saudi Central Bank first reported a position in AMGN in Q1 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Saudi Central Bank held 37,735 shares of Amgen worth $13.7M as of Q2 2026.
  • Saudi Central Bank bought 17,859 Amgen shares in Q2 2026, an estimated $6.11M.
  • Amgen made up 0.18% of Saudi Central Bank's portfolio in Q2 2026, its #85 holding.
  • Saudi Central Bank first reported a position in Amgen in Q1 2025 and has held it in 3 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.